Immune treatment for common cancer goes straight to the source

Bladder cancer is common, but it doesn’t get much attention.Safe and effective treatments are needed to treat this cancer early, with fewer negative side effects.As Professor Dickon Hayne explains, a first-in-human trial has injected a type of immunotherapy directly into the bladder to attack tumours, with some early success.